NYSEArca - Nasdaq Real Time Price USD

ALPS Medical Breakthroughs ETF (SBIO)

32.62 -0.41 (-1.24%)
As of 2:36 PM EDT. Market Open.

ETF Summary

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

Risk Overview

Performance & Risk

YTD Return 0.27%
5y Average Return -1.30%
Rank in Category (ytd) --
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.88
Morningstar Risk Rating --

Risk Statistics

3 Years5 Years10 Years
SBIOCategory AverageSBIOCategory AverageSBIOCategory Average
Alpha -12.92 -6.66 -7.27 -0.92 0 1.96
BETA 0.88 0.84 0.96 0.81 0 0.85
Mean Annual Return -0.58 -0.07 0.42 0.81 0 0.84
R-squared 24.83 54.78 32.55 56.13 0 51.83
Standard Deviation 29.33 19.37 29.72 19.6 0 17.88
Sharpe Ratio -0.35 -0.13 0.09 0.43 0 0.49
Treynor Ratio -15.77 -5.28 -1.65 8.15 0 8.64

Related Tickers